GM took position 4.27.20 prices were
Mdt stock $100, now $90. -10%
JNJ stock $154 now $181. +15%
ABT stock $95, now 107. +13%
Pathetic BSX $37, now $37. 0%
If we look at last 12 months, its worse. Hmm
Give the guy a break FFS - he just needs a little time
GM took position 4.27.20 prices were
Mdt stock $100, now $90. -10%
JNJ stock $154 now $181. +15%
ABT stock $95, now 107. +13%
Pathetic BSX $37, now $37. 0%
If we look at last 12 months, its worse. Hmm
Much more fun to throw a dart on a graph with endpoints you choose yourself and claim victory.
Com'on man. Supply chain, Covid, Russia, gas prices arent his fault. Oh wait, new structure, new leaders, Heartware, backorders, woke, Warning Letter, robotics, more recalls, loading, analyst confidence. Com'on man...
Every industry funded clinical trial strategy of the last 10 years!
How about just cleaning out the training department and starting over too - especially PF?
J&J and ABT stock price did ok due to the billions of govt dollars printed for them for vaccines and tests (thanks for the inflation guys). ABT has tanked this last year.
Better measures of a company’s financial health are measured by their P/E and P/S. Hmm
What’s a P/E and P/S? Sounds like you’re making stuff up. Geoff is probably trying to trick us and confuse everyone with fake news! Everyone knows all that matters is the stock price.
Geoff is a decent and honest person and means well. The Mission is real with him, I haven't seen him where he wasn't trying to do the right thing. He cares deeply about his people and gives his team credit where it is due. The truth is that the last couple of years have been tough across the board, and we are lucky to have a leader who at least can tell his head from his @$$. That's more than you can say for most CEOs. Naysayers are mostly people who couldn't cut it at the New Medtronic. That's all.
Geoff is a decent and honest person and means well. The Mission is real with him, I haven't seen him where he wasn't trying to do the right thing. He cares deeply about his people and gives his team credit where it is due. The truth is that the last couple of years have been tough across the board, and we are lucky to have a leader who at least can tell his head from his @$$. That's more than you can say for most CEOs. Naysayers are mostly people who couldn't cut it at the New Medtronic. That's all.
Welcome, PR department. Your promotion is ready.
J&J and ABT stock price did ok due to the billions of govt dollars printed for them for vaccines and tests (thanks for the inflation guys). ABT has tanked this last year.
Better measures of a company’s financial health are measured by their P/E and P/S. Hmm
Why does all of this matter. I want my mdt stock to grow. I dont care about those companies. Our company is worth less
